Neurohormone levels remain elevated in continuous flow left ventricular assist device recipients

Area of Science:

• Cardiology
• Biomedical Engineering
• Physiology

Background:

• Neurohormone levels are critical in heart failure (HF) and mechanical circulatory support.
• Continuous-flow left ventricular assist devices (CF-LVADs) aim to restore hemodynamic function.
• The impact of aortic valve status on neurohormone levels in CF-LVAD recipients requires further investigation.

Purpose of the Study:

• To compare neurohormone levels (aldosterone, norepinephrine, renin) in CF-LVAD recipients, HF patients, and healthy controls.
• To investigate the influence of aortic valve status (open vs. closed) on neurohormone levels in CF-LVAD recipients.

Main Methods:

• Neurohormone levels (aldosterone, norepinephrine, renin) were measured in 46 participants: 18 CF-LVAD recipients, 14 HF patients, and 14 healthy controls.
• Echocardiography assessed cardiac function and aortic valve status in CF-LVAD recipients.
• Neurohormone levels were compared between CF-LVAD recipients with open versus closed aortic valves.

Main Results:

• CF-LVAD recipients and HF patients exhibited similarly elevated levels of aldosterone, norepinephrine, and renin compared to healthy controls.
• Norepinephrine and aldosterone levels did not differ between CF-LVAD recipients with open or closed aortic valves.
• CF-LVAD recipients with open aortic valves showed higher renin levels than those with closed valves, though open AV was a weak predictor.

Conclusions:

• Neurohormone levels, including aldosterone, norepinephrine, and renin, do not normalize after CF-LVAD implantation, indicating persistent neurohormonal activation.
• Aortic valve status may influence renin levels in CF-LVAD recipients.
• Further research is needed to elucidate the mechanisms and clinical implications of elevated neurohormones and the role of aortic valve status in CF-LVAD patients.